vimarsana.com

Page 20 - நிபுணர் தடுப்பூசி ஒதுக்கீடு குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adults 50 Plus Eligible for Covid-19 Vaccine as of March 15

Coronavirus: Texas vaccination eligibility to include Phase 1C, people over 50, Monday

Outdated population data may be costing Texas millions of COVID-19 vaccine doses

Feds short-change Texas on COVID vaccine allocations, state leaders say FacebookTwitterEmail 1of4 Volunteers and medical personnel stand by to administer vaccines at the City of San Antonio s Alamodome COVID-19 Vaccine Site on Monday, Jan. 11, 2021.Lisa Krantz, Staff / Staff photographerShow MoreShow Less 2of4 People wait to make sure they are not having any adverse effects after receiving the COVID-19 vaccine at the City of San Antonio s Alamodome COVID-19 Vaccine Site on Monday, Jan. 11, 2021.Lisa Krantz, Staff / Staff photographerShow MoreShow Less 3of4 A large group of people wait, without appointments, for the possibility that there would be COVID-19 vaccine available after people with appointments had finished. There were only four doses remaining at the end of the evening at this University Health Vaccine site at Wunderland of the America s Mall.Robin Jerstad, San Antonio Express-News / ContributorShow MoreShow Less

Tens of thousands of doses administered to out-of-state travelers

AMARILLO Gina Ryanczak, a Santa Fe, N.M., resident, was on the waiting list to receive a vaccination shot in her home state, but she wasn t yet eligible.  New Mexico was in Phase 1B of its vaccination allocation plan, which limited vaccinations to seniors aged 75 or older and people with chronic health risks. At age 65 with mild asthma, Ryanczak wanted to get vaccinated sooner rather than later. So she headed for Texas. I figured, it’s worth taking a day off and driving over and getting a shot because I don’t want to wait until June, she said.  After a 300-mile drive to Amarillo, she waited just 15 minutes to get a shot at the city s Civic Center.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.